> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on IND Surveys Under User Fee Program
- URL: https://www.fdaweb.com/comments-sought-on-ind-surveys-under-user-fee-program/
- Published: 2018-08-16T12:00:00.000Z
- Updated: 2026-09-15T00:26:22.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142130

*Federal Register* notice: FDA is seeking comments on a new information collection entitled “Surveys and Interviews With Investigational New Drug (IND) Sponsors To Assess Current Communication Practices With FDA Review Staff Under the Sixth Authorization of the Prescription Drug User Fee Act (PDUFA VI).” As part PDUFA VI, FDA committed to a third-party assessment of current IND-phase communication practices. The contractor for the assessment of IND communication practices is Eastern Research Group, which will conduct surveys and interviews with sponsors of up to 150 active commercial INDs. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-08-16/pdf/2018-17715.pdf?ref=fdaweb.com).